Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study

NCT06162585 is registered in ClinicalTrials.gov with Nanoscope Therapeutics Inc. as lead sponsor.

NCT NCT06162585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06162585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study
Lead sponsor
Nanoscope Therapeutics Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 8, 2023
Completion date
September 30, 2027
Enrollment
18 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

eye diseases, eye diseases, hereditary, retinal degeneration, retinal diseases, retinal dystrophies, retinitis, retinitis pigmentosa